Last CNY26.53 CNY
Change Today -0.69 / -2.53%
Volume 11.7M
600557 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:06 AM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

jiangsu kanion pharmaceuti-a (600557) Snapshot

Open
CNY27.34
Previous Close
CNY27.22
Day High
CNY27.42
Day Low
CNY26.30
52 Week High
02/11/14 - CNY32.08
52 Week Low
04/25/14 - CNY21.71
Market Cap
13.2B
Average Volume 10 Days
8.3M
EPS TTM
CNY0.65
Shares Outstanding
498.8M
EX-Date
06/27/14
P/E TM
41.0x
Dividend
CNY0.10
Dividend Yield
0.38%
Current Stock Chart for JIANGSU KANION PHARMACEUTI-A (600557)

Related News

No related news articles were found.

jiangsu kanion pharmaceuti-a (600557) Related Businessweek News

No Related Businessweek News Found

jiangsu kanion pharmaceuti-a (600557) Details

Jiangsu Kanion Pharmaceutical Co. Ltd. is engaged in the contract manufacture of herb medicines primarily in China. The company’s services include formula design, workmanship design, lab inspection, trial production, purchase of materials for production and package, batch production, packing and labeling, bulk sale, and new product consultation and development services. It offers herb powders and extracts, diet supplements, herb medicines, and other products in various forms, including tablets, granules, hard capsules, soft gel capsules, oral liquids, TCM injections, and lyophilized powder injections. The company exports its products to Europe and North America. Jiangsu Kanion Pharmaceutical Co. Ltd. was founded in 1975 and is headquartered in Lianyungang, China.

Founded in 1975

jiangsu kanion pharmaceuti-a (600557) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiangsu kanion pharmaceuti-a (600557) Key Developments

Jiangsu Kanion Pharmaceutical Co. Ltd. Announces Earnings Results for the First Three Quarters of 2014

Jiangsu Kanion Pharmaceutical Co. Ltd. announced earnings results for the first three quarters of 2014. For the period, the company basic earning per share was CNY 0.501 and weighted average return on net assets was 12.58%.

Jiangsu Kanion Pharmaceutical Co. Ltd., Board Meeting, Oct 27, 2014

Jiangsu Kanion Pharmaceutical Co. Ltd., Board Meeting, Oct 27, 2014. Agenda: To approve the proposal of changing its accounting policy; and to consider the third quarter report of 2014.

Jiangsu Kanion Pharmaceutical Co. Ltd. to Report Q3, 2014 Results on Oct 28, 2014

Jiangsu Kanion Pharmaceutical Co. Ltd. announced that they will report Q3, 2014 results on Oct 28, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600557:CH CNY26.53 CNY -0.69

600557 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600557.
View Industry Companies
 

Industry Analysis

600557

Industry Average

Valuation 600557 Industry Range
Price/Earnings 42.1x
Price/Sales 5.5x
Price/Book 6.5x
Price/Cash Flow 42.1x
TEV/Sales 5.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIANGSU KANION PHARMACEUTI-A, please visit www.kanion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.